A Study to Evaluate the Safety, Tolerability, Pharmacokinetics of TB001 in Healthy Subjects

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2022
It was a randomized, double-blind, placebo-controlled combined single ascending dose (SAD) and multiple ascending dose (MAD) study, evaluating the safety, tolerability and pharmacokinetics of TB001 after single and multiple subcutaneous injections in healthy subjects.
Epistemonikos ID: dc10cd39ad8a19d569493ec2763ed44fc196753e
First added on: May 13, 2024